Each teaspoon (5 mL) of Triaminic® Night Time contains: pseudoephedrine hydrochloride USP 15 mg, dextromethorphan hydrobromide, USP 7.5 mg, chlorpheniramine maleate, USP 1 mg, in a palatable, grape-flavored, alcohol-free liquid.

Inactive ingredients:    benzoic acid, citric acid, D&C Red 33, dibasic sodium phosphate, FD&C Blue 1, flavors, propylene glycol, purified water, sorbitol, sucrose.

Sodium content: 22 mg per teaspoon.

  Temporarily relieves cold and allergy symptoms, including coughs due to minor throat and bronchial irritation, runny nose; stuffy nose; sneezing; itching of the nose or throat; and itchy, watery eyes.

:   Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a poison control center immediately.

Do not exceed recommended dosage. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor. If symptoms do not improve within 7 days or are accompanied by fever, consult a doctor. A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor. Do not take this product: 1) if cough is accompanied by excessive phlegm (mucus), 2) for persistent or chronic cough such as occurs with smoking, asthma or emphysema, 3) if you have heart disease, high blood pressure, thyroid disease, diabetes, glaucoma, a breathing problem such as emphysema or chronic bronchitis, or difficulty in urination due to enlargement of the prostate gland, or 4) if you are taking sedatives or tranquilizers, unless directed by a doctor. May cause excitability especially in children. May cause drowsiness; alcohol, sedatives or tranquilizers may increase the drowsiness effect. Avoid alcoholic beverages while taking this product. Use caution when driving a motor vehicle or operating machinery. Do not use this product if you are on a sodium restricted diet unless directed by a doctor. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

Drug Interaction Precaution:   Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson' disease) or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains an MAOI, consult a health professional before taking this product.

Dosage and Administration: Adults and children 12 and over (96+ lbs.)--4 teaspoons every 6 hours. Children 6 to under 12 years (48-95 lbs.)--2 teaspoons every 6 hours. Do not exceed 4 doses in 24 hours, or as directed by a doctor. Dosing to children under 6 years of age is to be under the direction of a physician. For convenience, a True-Dose® dosage cup is provided with each 4 fl. oz. and 8 fl. oz. bottle.

Professional Labeling:   The suggested dosage for pediatric patients is:

4 to under
  12 months
  (12-17 lbs.)
1 / 4 teaspoon or 1.25 ml
every 6 hours
12 months to
  under 2 years
  (18-23 lbs.)
1 / 2 teaspoon or 2.5 ml
every 6 hours
2 to under
  6 years
1 teaspoon or 5 ml
every 6 hours
Not to exceed 4 doses in 24 hours

How Supplied: Triaminic® Night Time Cough and Cold Medicine for Children (purple), in 4 fl. oz. and 8 fl. oz. plastic bottles packaged in cartons with tamper-evident band around child-resistant cap. Grape flavored. Alcohol free.

STORE AT ROOM TEMPERATURE.

PROTECT FROM LIGHT.

CONTAINS NO ASPIRIN.

NOVARTIS

©2000 Novartis Consumer Health, Inc.

Summit, NJ 07901-1312

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.